CELLBIXAN Trademark

Trademark Overview

On Wednesday, July 19, 2023, a trademark application was filed for CELLBIXAN with the United States Patent and Trademark Office. The USPTO has given the CELLBIXAN trademark a serial number of 79379913. The federal status of this trademark filing is REGISTERED as of Tuesday, October 1, 2024. This trademark is owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES. The CELLBIXAN trademark is filed in the Pharmaceutical Products category with the following description:

Anti-CD20 recombinant monoclonal antibody for medical use
cellbixan

General Information

Serial Number79379913
Word MarkCELLBIXAN
Filing DateWednesday, July 19, 2023
Status700 - REGISTERED
Status DateTuesday, October 1, 2024
Registration Number7518485
Registration DateTuesday, October 1, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2024

Trademark Statements

Goods and ServicesAnti-CD20 recombinant monoclonal antibody for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Saturday, October 14, 2023APPLICATION FILING RECEIPT MAILED
Thursday, October 5, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, October 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, March 24, 2024ASSIGNED TO EXAMINER
Tuesday, March 26, 2024NON-FINAL ACTION WRITTEN
Saturday, April 13, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 27, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, April 13, 2024REFUSAL PROCESSED BY MPU
Saturday, May 4, 2024NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, May 8, 2024REFUSAL PROCESSED BY IB
Tuesday, May 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 26, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 4, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, October 1, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, January 1, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 4, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 5, 2025GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, May 20, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 20, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 20, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 20, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 29, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 5, 2025GENERIC MADRID TRANSACTION CREATED
Saturday, March 22, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Related Keywords

cellbixan medical antibody monoclonal recombinant anti